ClinicalTrials.Veeva

Menu

Serious Games Rehabilitation Programme to Treat Gait and Balance Disorders in PD Patients (PARKGAME-II)

I

Institut National de la Santé Et de la Recherche Médicale, France

Status

Completed

Conditions

Parkinson Disease

Treatments

Device: Placebo serious game
Device: Serious game

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

To test the effects of a serious game rehabilitation programme in 50 patients with Parkinson's disease with gait and balance disorders in a randomised controlled study

Enrollment

25 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Parkinson's disease
  • Gait and balance disorders resistant to dopaminergic medication

Exclusion criteria

  • dementia
  • contra-indication to magnetic resonance imaging

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

25 participants in 2 patient groups, including a placebo group

Rehabilitation with active serious game
Active Comparator group
Description:
25 patients will perform motor rehabilitation programme using the serious game
Treatment:
Device: Serious game
No active serious game
Placebo Comparator group
Description:
25 patients will not perform motor rehabilitation programme using the serious game
Treatment:
Device: Placebo serious game

Trial contacts and locations

1

Loading...

Central trial contact

Marie Laure Welter, PH MD PHD; Marie-Laure WELTER, PH MD PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems